Previous Article | Next Article ![]()
Applied and Environmental Microbiology, January 2000, p. 29-35, Vol. 66, No. 1
IBEX Technologies Inc., Montreal, Quebec H4P
1P7, Canada
Received 22 September 1999/Accepted 17 October 1999
In medium supplemented with chondroitin sulfate,
Flavobacterium heparinum synthesizes and exports two
chondroitinases, chondroitinase AC (chondroitin AC lyase; EC 4.2.2.5)
and chondroitinase B (chondroitin B lyase; no EC number), into its
periplasmic space. Chondroitinase AC preferentially depolymerizes
chondroitin sulfates A and C, whereas chondroitinase B degrades only
dermatan sulfate (chondroitin sulfate B). The genes coding for both
enzymes were isolated from F. heparinum and
designated cslA (chondroitinase AC) and cslB (chondroitinase B). They were found to be separated by 5.5 kb on the
chromosome of F. heparinum, transcribed in the
same orientation, but not linked to any of the heparinase
genes. In addition, the synthesis of both enzymes appeared to be
coregulated. The cslA and cslB DNA sequences
revealed open reading frames of 2,103 and 1,521 bp coding for peptides
of 700 and 506 amino acid residues, respectively. Chondroitinase AC has
a signal sequence of 22 residues, while chondroitinase B is composed of
25 residues. The mature forms of chondroitinases AC and B are
comprised of 678 and 481 amino acid residues and have calculated
molecular masses of 77,169 and 53,563 Da, respectively. Truncated
cslA and cslB genes have been used to produce
active, mature chondroitinases in the cytoplasm of Escherichia
coli. Partially purified recombinant chondroitinases AC and B
exhibit specific activities similar to those of chondroitinases AC and
B from F. heparinum.
0099-2240/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Isolation and Expression in Escherichia coli of
cslA and cslB, Genes Coding for the
Chondroitin Sulfate-Degrading Enzymes Chondroitinase AC and
Chondroitinase B, Respectively, from Flavobacterium
heparinum



*
Corresponding author. Mailing address: IBEX
Technologies Inc., 5485 Pare, Montreal, Quebec H4P 1P7, Canada. Phone:
(514) 344-4004. Fax: (514) 344-8827. E-mail: Suho{at}Ibex.Ca.
Present address: Bio-Mega, Research Division of Boehringer
Ingelheim (Canada) Ltd., Laval, Quebec H7S 2G5, Canada.
Present address: Bristol-Myers Squibb, Saint-Laurent,
Quebec H4N 2M7, Canada.
§
Present address: Pfizer, Animal Health Central Research,
Groton, CT 06340.
Present address: Diversa Corporation, San Diego, CA 92121.
#
Present address: The Millennium Three Group, Rosemont, PA 19010.
This article has been cited by other articles:
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|